Company intelligence / Profile preview

yet2

Boston, Massachusetts, United Statesyet2.com ↗

Ownership: Private
Employees: ~75
Development stage: Other

Overview

yet2 provides open innovation consulting and technology scouting services to life science, biotech, pharma, healthcare companies and beyond. It connects organizations with external innovations—such as new diagnostics or delivery technologies—and facilitates partnerships but does not itself conduct clinical trials or have clinical results[1][3].

Industry: Consulting

Partnerships

CSL Behring / CSL Group—operates the CSL Open Innovation portal in partnership with CSL to facilitate external collaborations in immunology, hematology, respiratory diseases, cardiovascular/metabolic disorders, transplant medicine and vaccines among others[6][8].Kobayashi Pharmaceuticals—facilitated joint research agreements through open innovation portal [3].

Beyond the preview

Go deeper on yet2.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yet2.

Explore the full profile